ECU
BIIB icon

Eisler Capital (UK)’s Biogen BIIB Stock Holding History

Eisler Capital (UK)’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$1.01M Hold
5,200
– – ﹤0.01% 483
2024
Q2 		$1.21M Buy
+5,200
New +$1.13M 0.01% 431

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Eisler Capital (UK)'s BIIB Position: Q3 2024 in Review

Eisler Capital (UK) opened a new position in Biogen (BIIB) in Q3 2024: 3,766 shares worth $730K. The stake represents ﹤0.01% of the portfolio and ranks #509 among its holdings. This is a return to the name: Eisler Capital (UK) previously reported a position in BIIB as recently as Q1 2024.

Eisler Capital (UK) first reported a position in BIIB in Q1 2022 and has held it in 7 quarters since. The position peaked at $8.66M in Q3 2023. 916 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • Eisler Capital (UK) held 3,766 shares of Biogen worth $730K as of Q3 2024.
  • Biogen was a new Eisler Capital (UK) position in Q3 2024.
  • Biogen made up ﹤0.01% of Eisler Capital (UK)'s portfolio in Q3 2024, its #509 holding.
  • Eisler Capital (UK) first reported a position in Biogen in Q1 2022 and has held it in 7 quarters since.
  • Eisler Capital (UK)'s Biogen position peaked at $8.66M in Q3 2023.
  • 916 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on Eisler Capital (UK)'s 13F filing for Q3 2024, filed 14 Nov 2024.